PubMed · 6622977
Amrinone-mediated thrombocytopenia.
Abstract
Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
E L Kinney, J O Ballard, B Carlin, R Zelis. 1983. Amrinone-mediated thrombocytopenia.. https://doi.org/10.1111/j.1600-0609.1983.tb00665.x
Cite the original work for its findings. Save a collection to share your selection of sources.